Hikma Pharmaceuticals PLC - EIP B and EIP C Vesting
LONDON, 17 May 2021: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 17 May 2019 under the 2014 Executive Incentive Plan ("EIP") Element B and granted on 16 May 2018 under the 2014 EIP Element C. The Element B awards vested two years after grant and the Element C awards vested three years after grant.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Mazen Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mazen Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Vice Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 12,042 |
| d) | Aggregated information - Volume - Price
Total |
12,042 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Riad Mishlawi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Riad Mishlawi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 22,601 |
| d) | Aggregated information - Volume - Price
- Total |
22,601 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Majda Labadi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Majda Labadi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 15,855 |
| d) | Aggregated information - Volume - Price
- Total |
15,855 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Bassam Kanaan
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Bassam Kanaan |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 25,729 |
| d) | Aggregated information - Volume - Price
- Total |
25,729 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Khalid Nabilsi
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Khalid Nabilsi |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 23,062 |
| d) | Aggregated information - Volume - Price
- Total |
23,062 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Susan Ringdal
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Susan Ringdal |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 7,522
Price(s): £23.835 Volume(s): 6,735 |
| d) | Aggregated information - Volume - Price
- Total |
14,257 £23.835 £160,528.73p |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Hussein Arkhagha
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Hussein Arkhagha |
| 2 | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Shares acquired from the vesting of conditional awards on |
| c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 11,246 |
| d) | Aggregated information - Volume - Price
- Total |
11,246 £0.00 £0.00 |
| e) | Date of the transaction | 17 May 2021 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
17 May 2021
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
